Core Laboratories Inc. (NYSE:CLB) Shares Acquired by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its stake in Core Laboratories Inc. (NYSE:CLB) by 21.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 753,555 shares of the oil and gas company’s stock after purchasing an additional 133,375 shares during the quarter. Fisher Asset Management LLC owned about 1.61% of Core Laboratories worth $13,308,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC acquired a new position in shares of Core Laboratories during the 3rd quarter valued at about $31,000. GAMMA Investing LLC purchased a new stake in shares of Core Laboratories in the 4th quarter valued at approximately $48,000. PNC Financial Services Group Inc. raised its position in shares of Core Laboratories by 72.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock valued at $144,000 after buying an additional 2,533 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Core Laboratories by 31.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company’s stock valued at $259,000 after buying an additional 2,566 shares during the period. Finally, Morningstar Investment Services LLC grew its position in Core Laboratories by 6.0% in the third quarter. Morningstar Investment Services LLC now owns 13,570 shares of the oil and gas company’s stock worth $333,000 after acquiring an additional 764 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Price Performance

Shares of CLB opened at $15.92 on Monday. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68. Core Laboratories Inc. has a fifty-two week low of $13.82 and a fifty-two week high of $27.94. The company has a market cap of $746.65 million, a P/E ratio of 18.09, a PEG ratio of 0.90 and a beta of 2.40. The firm’s 50 day moving average price is $16.50 and its 200 day moving average price is $17.30.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. The business had revenue of $129.64 million for the quarter, compared to analysts’ expectations of $124.47 million. On average, research analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Monday, May 6th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.25%. Core Laboratories’s payout ratio is 4.55%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CLB shares. Bank of America decreased their price target on Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research note on Monday, April 15th. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, January 20th. Finally, Stifel Nicolaus upped their price objective on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, April 26th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $18.75.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.